Evaluation of the practicability of a finger-stick whole-blood SARS-Cov-2 self-test adapted for the general population.

<h4<Background</h4<COVID-19 (COronaVIrus Disease 2019) is an infectious respiratory disease caused by the novel SARS-CoV-2 virus. Point of Care (POC) tests have been developed to detect specific antibodies, IgG and IgM, to SARS-CoV-2 virus in human whole blood. They need to be easily usable by the general population in order to alleviate the lockdown that many countries have initiated in response to the growing COVID-19 pandemic. A real-life study has been conducted in order to evaluate the performance of the COVID-PRESTO® POC test and the results were recently published. Even if this test showed very high sensitivity and specificity in a laboratory setting when used by trained professionals, it needs to be further evaluated for practicability when used by the general public in order to be approved by health authorities for in-home use.<h4<Methods</h4<143 participants were recruited between March 2020 and April 2020 among non-medical populations in central France (nuclear plant workers, individuals attending the Orleans University Hospital vaccination clinic and Orleans University Hospital non-medical staff). Instructions for use, with or without a tutorial video, were made available to the volunteers. Two separate objectives were pursued: evaluation of the capability of participants to obtain an interpretable result, and evaluation of the users' ability to read the results.<h4<Results</h4<88.4% of the test users judged the instructions for use leaflet to be clear and understandable. 99.3% of the users obtained a valid result and, according to the supervisors, 92.7% of the tests were properly performed by the users. Overall, 95% of the users gave positive feedback on the COVID PRESTO® as a potential self-test. Neither age nor education had an influence.<h4<Conclusion</h4<COVID-PRESTO® was successfully used by an overwhelming majority of participants and its use was judged very satisfactory, therefore showing promising potential as a self-test to be used by the general population. This POC test can become an easy-to-use tool to help detect whether individuals are protected or not, particularly in the context of a second wave or a mass vaccination program..

Medienart:	E-Artikel

Erscheinungsjahr:	2021
Erschienen:	2021

Enthalten in:	Zur Gesamtaufnahme - volume:16
Enthalten in:	PLoS ONE - 16(2021), 1, p e0245848

Sprache:	Englisch

Beteiligte Personen:	Thierry Prazuck [VerfasserIn] Jean Phan Van [VerfasserIn] Florence Sinturel [VerfasserIn] Frederique Levray [VerfasserIn] Allan Elie [VerfasserIn] Denise Camera [VerfasserIn] Gilles Pialoux [VerfasserIn]

Links:	doi.org [kostenfrei] doaj.org [kostenfrei] doi.org [kostenfrei] Journal toc [kostenfrei]

Themen:	Medicine Q R Science

doi:	10.1371/journal.pone.0245848

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	DOAJ003833232